Cardlytics filings document a Nasdaq-listed commerce media company's operating results, governance, capital structure, and material events. Form 8-K reports furnish quarterly and annual results, conference-call materials, cost-reduction actions, leadership and compensatory arrangements, and securities information for the company's common stock listed under CDLX.
The filing record also includes disclosure on the completed divestiture of Bridg, including the asset-sale closing and related unaudited pro forma financial statements. Proxy materials cover board matters, shareholder voting items, executive compensation, equity awards, and related governance disclosures for the company’s commerce media business.
Cardlytics, Inc. (CDLX) Chief Executive Officer Amit Gupta converted 18,750 and 12,500 restricted stock units into common shares on October 1, 2026; the reported RSU balances afterward were 112,500 and 25,000, respectively. He sold 10,351 shares that day at a weighted average of $2.710 per share, at prices ranging from $2.62 to $2.94, and sold 7,382 shares on October 2 at a weighted average of $2.533 per share, at prices ranging from $2.48 to $2.635. No Rule 10b5-1 plan is reported.
Cardlytics, Inc. (CDLX) officer and director Amit Gupta reported a proposed sale of 7,382 common shares, with an aggregate market value of $18,700.82 and an approximate sale date of October 2, 2026. The shares were reported as restricted stock vested October 1, 2026; the notice states that the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award.
Cardlytics, Inc. (CDLX) is named as issuer in Amit Gupta's notice covering a proposed sale of 10,351 common shares, with an aggregate market value of $28,051.21 and an approximate sale date of October 1, 2026. Gupta is identified as an officer and director. The shares are listed as restricted-stock vesting compensation, and the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution. Fidelity Brokerage Services LLC is listed as broker.
Cardlytics, Inc. (CDLX) disclosed that it has entered into a Settlement Agreement with Amit Jain, founder and former CEO and director of Bridg, resolving his claim for advancement and indemnification of legal fees and expenses. The parties agreed to an aggregate payment of $6.4 million, covering Mr. Jain’s approximately $5.3 million allocated portion of the DailyGobble Action settlement and related costs, plus $1.1 million for legal fees related to that action.
The company states that this settlement amount is consistent with the $6.5 million accrual it had already recorded as of June 30, 2026. Cardlytics is seeking insurance reimbursement that it believes should apply to this matter, which could offset some of the costs.
Cardlytics, Inc. (symbol: CDLX) is the issuer of record for a Form 4/A filing submitted to the SEC.
Cardlytics, Inc. (symbol: CDLX) is the issuer of record for a Form 4/A filing submitted to the SEC.
Cardlytics, Inc. (symbol: CDLX) is the issuer of record for a Form 4/A filing submitted to the SEC.
Cardlytics, Inc. (symbol: CDLX) is the issuer of record for a Form 4/A filing submitted to the SEC.
Cardlytics, Inc. (symbol: CDLX) is the issuer of record for a Form 4/A filing submitted to the SEC.
Cardlytics, Inc. (symbol: CDLX) is the issuer of record for a Form 4/A filing submitted to the SEC.